CAS: 2260886-64-2
N-(trans-4-(3-(2-Chlorophenyl)-7-((3-methyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)cyclohexyl)propionamide
CAS:2260886-64-2
Formula:
C33H41ClN8O2
Purity:
99+%
Molecular weight:
617.1840
Ref: AN-AG01KL3B
| 1mg | 227.00 € | ||
| 5mg | 474.00 € | ||
| 50mg | 626.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
JND3229
CAS:2260886-64-2
JND3229 is a synthetic, non-small-cell EGFR inhibitor that targets the kinase domain of EGFR. It …
Formula:
C33H41ClN8O2
Purity:
Min. 95%
Molecular weight:
617.2 g/mol
Ref: 3D-KQD88664
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 26 Aug 2024
JND3229
CAS:2260886-64-2
JND3229 inhibits EGFRC797S; IC50: 5.8-30.5 nM; halts cell growth; effective in non-small cell lung cancer …
Formula:
C33H41ClN8O2
Purity:
97.35%
Color and Shape:
Solid
Molecular weight:
617.18
Ref: TM-T15615
| 1mg | 123.00 € | ||
| 1ml | 419.00 € | ||
| 5mg | 303.00 € | ||
| 10mg | 456.00 € | ||
| 25mg | 754.00 € | ||
| 50mg | 1,049.00 € |
Estimated delivery in United States, on Monday 16 Sep 2024
